Muscular Dystrophy UK’s FastTrack campaign is focused on faster access to treatments.
For people with muscle-wasting conditions, every day is vital and we are committed to ensuring urgent action is taken so that people are able to access the support and treatments that they want and need.
This is an encouraging time with many clinical trials in development, and several treatments either available or emerging on the horizon. Once treatments are available it is crucial that people are able to access them quickly. When access to treatments is delayed it is families who suffer. Our FastTrack to treatments campaign is committed to identifying and removing the barriers that cause delays to ensure that patients are able to access and benefit from new, safe and effective treatments as quickly as possible.
The SMA gene therapy Zolgensma has today been grant
NICE, NHS England and NHS Improvement have taken advice
Joint letter to NICE regarding ridisplam
Join us for our Virtual Celebrity Sports Quiz